News
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...
Futurism on MSN4h
A Side Effect of Trump's Tariffs: Making Ozempic Way More Expensive
President Donald Trump's new European tariffs may spell bad news for Novo Nordisk, maker of Ozempic and Wegovy. As Axios ...
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...
Best Life on MSN1d
Ozempic Patients Report Another Troubling Side Effect: “I’ve Lost at Least Half My Hair”
Doctors explain that hair loss related to drugs like Ozempic is usually a result of rapid weight loss, not the medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback